Glucometer Market Report: Trends, Forecast and Competitive Analysis to 2030
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
1. EXECUTIVE SUMMARY
2. GLOBAL GLUCOMETER MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Glucometer Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Glucometer Market by Product
3.3.1: Continuous Glucose Monitoring Devices
3.3.2: Self-Monitoring Blood Glucose Systems
3.4: Global Glucometer Market by Technique
3.4.1: Invasive
3.4.2: Non-Invasive
3.5: Global Glucometer Market by Type
3.5.1: Wearable
3.5.2: Non-Wearable
3.6: Global Glucometer Market by Distribution Channel
3.6.1: Institutional Sales
3.6.2: Hospitals
3.6.3: Clinics
3.6.4: Retail Sales
3.6.5: Hospital Pharmacies
3.6.6: Retail Pharmacies
3.6.7: Online Pharmacies
3.6.8: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Glucometer Market by Region
4.2: North American Glucometer Market
4.2.2: North American Glucometer Market by Technique: Invasive and Non-Invasive
4.2.3: North American Glucometer Market by Type: Wearable and Non-Wearable
4.2.4: North American Glucometer Market by Distribution Channel: Institutional Sales, Hospitals, Clinics, Retail Sales, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others
4.3: European Glucometer Market
4.3.1: European Glucometer Market by Product: Continuous Glucose Monitoring Devices and Self-Monitoring Blood Glucose Systems
4.3.2: European Glucometer Market by Technique: Invasive and Non-Invasive
4.3.3: European Glucometer Market by Type: Wearable and Non-Wearable
4.3.4: European Glucometer Market by Distribution Channel: Institutional Sales, Hospitals, Clinics, Retail Sales, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others
4.4: APAC Glucometer Market
4.4.1: APAC Glucometer Market by Product: Continuous Glucose Monitoring Devices and Self-Monitoring Blood Glucose Systems
4.4.2: APAC Glucometer Market by Technique: Invasive and Non-Invasive
4.4.3: APAC Glucometer Market by Type: Wearable and Non-Wearable
4.4.4: APAC Glucometer Market by Distribution Channel: Institutional Sales, Hospitals, Clinics, Retail Sales, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others
4.5: ROW Glucometer Market
4.5.1: ROW Glucometer Market by Product: Continuous Glucose Monitoring Devices and Self-Monitoring Blood Glucose Systems
4.5.2: ROW Glucometer Market by Technique: Invasive and Non-Invasive
4.5.3: ROW Glucometer Market by Type: Wearable and Non-Wearable
4.5.4: ROW Glucometer Market by Distribution Channel: Institutional Sales, Hospitals, Clinics, Retail Sales, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Glucometer Market by Product
6.1.2: Growth Opportunities for the Global Glucometer Market by Technique
6.1.3: Growth Opportunities for the Global Glucometer Market by Type
6.1.4: Growth Opportunities for the Global Glucometer Market by Distribution Channel
6.1.5: Growth Opportunities for the Global Glucometer Market by Region
6.2: Emerging Trends in the Global Glucometer Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Glucometer Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Glucometer Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Thermo Fisher Scientific
7.2: Promega Corporation
7.3: Agilent Technologies
7.4: Bio-Rad Laboratories
7.5: QIAGEN
7.6: Merck
7.7: B.D.
7.8: Sanofi
7.9: Ascensia Diabetes Care Holdings
7.10: Abbott
2. GLOBAL GLUCOMETER MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Glucometer Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Glucometer Market by Product
3.3.1: Continuous Glucose Monitoring Devices
3.3.2: Self-Monitoring Blood Glucose Systems
3.4: Global Glucometer Market by Technique
3.4.1: Invasive
3.4.2: Non-Invasive
3.5: Global Glucometer Market by Type
3.5.1: Wearable
3.5.2: Non-Wearable
3.6: Global Glucometer Market by Distribution Channel
3.6.1: Institutional Sales
3.6.2: Hospitals
3.6.3: Clinics
3.6.4: Retail Sales
3.6.5: Hospital Pharmacies
3.6.6: Retail Pharmacies
3.6.7: Online Pharmacies
3.6.8: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Glucometer Market by Region
4.2: North American Glucometer Market
4.2.2: North American Glucometer Market by Technique: Invasive and Non-Invasive
4.2.3: North American Glucometer Market by Type: Wearable and Non-Wearable
4.2.4: North American Glucometer Market by Distribution Channel: Institutional Sales, Hospitals, Clinics, Retail Sales, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others
4.3: European Glucometer Market
4.3.1: European Glucometer Market by Product: Continuous Glucose Monitoring Devices and Self-Monitoring Blood Glucose Systems
4.3.2: European Glucometer Market by Technique: Invasive and Non-Invasive
4.3.3: European Glucometer Market by Type: Wearable and Non-Wearable
4.3.4: European Glucometer Market by Distribution Channel: Institutional Sales, Hospitals, Clinics, Retail Sales, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others
4.4: APAC Glucometer Market
4.4.1: APAC Glucometer Market by Product: Continuous Glucose Monitoring Devices and Self-Monitoring Blood Glucose Systems
4.4.2: APAC Glucometer Market by Technique: Invasive and Non-Invasive
4.4.3: APAC Glucometer Market by Type: Wearable and Non-Wearable
4.4.4: APAC Glucometer Market by Distribution Channel: Institutional Sales, Hospitals, Clinics, Retail Sales, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others
4.5: ROW Glucometer Market
4.5.1: ROW Glucometer Market by Product: Continuous Glucose Monitoring Devices and Self-Monitoring Blood Glucose Systems
4.5.2: ROW Glucometer Market by Technique: Invasive and Non-Invasive
4.5.3: ROW Glucometer Market by Type: Wearable and Non-Wearable
4.5.4: ROW Glucometer Market by Distribution Channel: Institutional Sales, Hospitals, Clinics, Retail Sales, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Glucometer Market by Product
6.1.2: Growth Opportunities for the Global Glucometer Market by Technique
6.1.3: Growth Opportunities for the Global Glucometer Market by Type
6.1.4: Growth Opportunities for the Global Glucometer Market by Distribution Channel
6.1.5: Growth Opportunities for the Global Glucometer Market by Region
6.2: Emerging Trends in the Global Glucometer Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Glucometer Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Glucometer Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Thermo Fisher Scientific
7.2: Promega Corporation
7.3: Agilent Technologies
7.4: Bio-Rad Laboratories
7.5: QIAGEN
7.6: Merck
7.7: B.D.
7.8: Sanofi
7.9: Ascensia Diabetes Care Holdings
7.10: Abbott
